• Bookmark this Page
  • Print this Page

Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)

Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)

The Molecular Basis for Cognitive Impairment in Parkinson's Disease (GAC 0156)

Protocol ID:
06-108T

Protocol Description

The purpose of this study is to measure different types of brain function in patients with Parkinson's disease (PD).

Eligibility Criteria

Patients with Parkinson's disease (PD)

Primary Investigator(s)

Andrew Feigin, MD

Contact Information

Toni Flanagan
(516) 562-2685
tflanaga@nshs.edu